Spalding T A, Burstein E S, Henderson S C, Ducote K R, Brann M R
ACADIA Pharmaceuticals, Inc., San Diego, California 92121, USA.
J Biol Chem. 1998 Aug 21;273(34):21563-8. doi: 10.1074/jbc.273.34.21563.
G-protein-coupled receptors spontaneously switch between active and inactive conformations. Agonists stabilize the active conformation, whereas antagonists stabilize the inactive conformation. In a systematic search for residues that participate in receptor function, several regions of the m5 muscarinic receptor were randomly mutated and tested for their functional properties. Mutations spanning one face of transmembrane 6 (TM6) were found to induce high levels of receptor activity in the absence of agonists (constitutive activity). The same face of TM6 contained several residues crucial for receptor activation by agonists and one residue identified as a contact site for both agonists and antagonists. In addition, one mutation induced agonist-like responses from the receptor when exposed to classical antagonists. These results suggest that TM6 is a switch that defines the activation state of the receptor, and that ligand interactions with TM6 stabilize the receptor in either an active or an inactive conformation.
G蛋白偶联受体可在活性构象和非活性构象之间自发切换。激动剂可稳定活性构象,而拮抗剂则稳定非活性构象。在对参与受体功能的残基进行系统搜索时,对m5毒蕈碱受体的几个区域进行了随机突变,并测试了它们的功能特性。发现跨膜6(TM6)一个面的突变在没有激动剂的情况下可诱导高水平的受体活性(组成性活性)。TM6的同一面包含几个对激动剂激活受体至关重要的残基,以及一个被确定为激动剂和拮抗剂接触位点的残基。此外,一个突变在暴露于经典拮抗剂时可诱导受体产生类似激动剂的反应。这些结果表明,TM6是定义受体激活状态的开关,并且配体与TM6的相互作用可使受体稳定在活性或非活性构象中。